(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

MUNTANA

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

MUNTANA

ST13

US500000098488858

Classe

1, 5, 42, 44

Pedido

98488858

Registro

7972275

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

22

Atualização mais recente

08/10/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

1, 5, 42, 44

Data de depósito

08/04/2024

Data de registro

07/10/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

07/10/2025

Última transação

08/10/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Fundamento do pedido

Intent to use, Foreign priority

Código do desenho

4

Tipo de titular

99

Localização do titular

Derio, Vizcaya, ES

Examinador

MARTIN,LIEF ANDREW

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

Asociación Centro de Investigación Cooperativa en Biociencias-CIC bioGUNE

Representantes

aoi nawashiro FisherBroyles, LLP

Classificação técnica

Classes Nice

Classe 1Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 1

Enzymes for industrial purposes; Enzymes for scientific purposes; Enzyme preparations for industrial purposes; Enzyme preparations for scientific purposes; Enzymes for genome editing for scientific and research purposes; Enzymes preparations for genome editing for scientific and research purposes; Diagnostic preparationsother than for medical or veterinary purposes; Reagents for scientific purposes; Reagents for research purposes; Reagents for genome editing for scientific and research purposes; Crispr inhibitors being biochemicalchemicalbiological preparations for scientific and research purposes; Crispr controls being biochemicalchemicalbiological preparations for scientific and research purposes; Crispr reagents for genome editing for scientific and research purposes; Chemical substances for use in the biotechnological industry; Chemical reagents for use in biotechnologyother than for medical or veterinary use; Chemical preparations for use in DNA analysisother than medical use; Enzyme preparations for use in DNA analysisother than medical use; Enzymes for use in DNA analysisother than medical use; Chemical preparations for use in RNA analysisother than medical use; Enzyme preparations for use in RNA analysisother than medical use; Enzymes for use in RNA analysisother than medical use; Enzymes for editing genomes for medical or veterinary research purposes

Classe 5

Enzymes for medical purposes; Enzymes for veterinary purposes; Enzyme preparations for medical purposes; Enzyme preparations for veterinary purposes; Enzyme preparations for editing genomes for medical or veterinary purposes; Diagnostic preparations for medical purposes; Diagnostic preparations for veterinary purposes; Reagents for use in medical genetic testing; Reagents for use in veterinary genetic testing; Reagents for genome editing for medical or veterinary purposes; Crispr inhibitors being biochemicalchemicalbiological preparations for medical or veterinary purposes; Crispr controls being biochemicalchemicalbiological preparations for medical or veterinary purposes; Crispr reagents for genome editing for medical or veterinary purposes; Chemical preparations for use in DNA analysis for medical or veterinary purposes; Enzyme preparations for use in DNA analysis for medical or veterinary purposes; Enzymes for use in DNA analysis for medical or veterinary purposes; Chemical preparations for use in RNA analysis for medical or veterinary purposes; Enzyme preparations for use in RNA analysis for medical or veterinary purposes; Enzymes for use in RNA analysis for medical or veterinary purposes

Classe 42

Research in the field of gene therapy; Advisory services relating to gene therapy research; Research in the field of gene editing technology; Advisory services in the field of gene editing technology; Genome editing for scientific purposes; Genome editing for scientific research purposes; Genome editing for industrial purposes; Genome editing for use in biotechnologyother than for medical or veterinary use

Classe 44

Genome editing for medical purposes; Genome editing for veterinary purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

22 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/10/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

07/10/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

03/10/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

19/08/2025

PUBO

PUBLISHED FOR OPPOSITION

19/08/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

13/08/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

14/07/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

18/06/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

18/06/2025

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

18/06/2025

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

31/01/2025

GNSL

LETTER OF SUSPENSION E-MAILED

31/01/2025

CNSL

SUSPENSION LETTER WRITTEN

31/01/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/01/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/01/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/01/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

21/10/2024

GNRT

NON-FINAL ACTION E-MAILED

21/10/2024

CNRT

NON-FINAL ACTION WRITTEN

21/10/2024

DOCK

ASSIGNED TO EXAMINER

21/10/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

15/09/2024

NWAP

NEW APPLICATION ENTERED

08/04/2024

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace MUNTANA ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.